Senzime AB (publ)
STO:SEZI
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Senzime AB (publ)
STO:SEZI
|
SE |
|
V
|
Viagold Rare Earth Resources Holdings Ltd
ASX:VIA
|
AU |
|
Bauer AG
XETRA:B5A
|
DE |
|
POSaBIT Systems Corp
OTC:POSAF
|
US |
Senzime AB (publ)
Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2008-06-18. The firm focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Senzime AB engages in the development of enzyme-based biosensor technology for medical and biochemical processes and industries. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2008-06-18. The firm focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
